12:35 IST
BSE
Fund Raise
Sudarshan Pharma Industries Fund Raise of ₹96 Cr
Sudarshan Pharma allotted ₹96 Crore worth of FCCBs due 2029. This capital infusion strengthens liquidity and provides a route for future equity conversion.
- Value
- ₹96.00 Cr
- Execution
- 3 years